Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45.22	81.02	70.99	162.7	294.23	1,661
Short-Term Investments	378.63	423.4	682.19	1,110	1,448	438.47
Cash & Short-Term Investments	423.85	504.42	753.18	1,272	1,742	2,100
Cash Growth	-40.89%	-33.03%	-40.81%	-26.96%	-17.02%	108.21%
Accounts Receivable	10.73	9.53	84.41	15.16	19.61	-
Other Receivables	2.7	3.4	4.2	-	-	-
Receivables	13.43	12.93	88.61	15.16	19.61	-
Inventory	-	-	1.5	1.7	1.4	-
Prepaid Expenses	17.19	13.95	24.73	47.63	37.34	22.82
Restricted Cash	-	-	1.33	-	-	-
Total Current Assets	454.48	531.3	869.35	1,337	1,801	2,122
Property, Plant & Equipment	11.14	11.64	6.38	13.43	19.13	31.82
Other Long-Term Assets	4.06	4.28	6.55	6.04	5.52	5.06
Total Assets	469.67	547.22	882.28	1,356	1,825	2,159
Accounts Payable	5.44	12.7	10.32	18.95	10.45	3.69
Accrued Expenses	35.75	42.29	56.68	72.67	67.28	54.85
Current Portion of Leases	1.81	1.32	5.17	7.64	7.47	8.66
Other Current Liabilities	6.78	15.31	10.59	-	-	-
Total Current Liabilities	49.78	71.62	82.75	99.26	85.19	67.2
Long-Term Leases	10.04	10.52	-	4.49	10.96	19.44
Other Long-Term Liabilities	-	-	-	0.1	0.1	0.27
Total Liabilities	59.82	82.13	82.75	103.85	96.26	86.91
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,443	3,436	3,370	3,291	3,227	3,110
Retained Earnings	-3,033	-2,970	-2,570	-2,028	-1,495	-1,037
Treasury Stock	-0.4	-0.4	-0.4	-0.4	-0.4	-0.4
Comprehensive Income & Other	0.14	0.24	-0.81	-10.21	-2.66	0.42
Shareholders' Equity	409.85	465.09	799.53	1,253	1,729	2,072
Total Liabilities & Equity	469.67	547.22	882.28	1,356	1,825	2,159
Total Debt	11.86	11.84	5.17	12.13	18.43	28.1
Net Cash (Debt)	412	492.58	748.02	1,260	1,724	2,071
Net Cash Growth	-42.27%	-34.15%	-40.65%	-26.89%	-16.78%	113.26%
Net Cash Per Share	6.73	8.11	12.50	21.25	29.38	39.08
Filing Date Shares Outstanding	62.62	61.48	60.11	59.72	59.05	58.38
Total Common Shares Outstanding	62.54	61.36	60.04	59.51	58.94	58.31
Working Capital	404.7	459.69	786.6	1,238	1,715	2,055
Book Value Per Share	6.55	7.58	13.32	21.05	29.34	35.54
Tangible Book Value	409.85	465.09	799.53	1,253	1,729	2,072
Tangible Book Value Per Share	6.55	7.58	13.32	21.05	29.34	35.54
Machinery	-	1.67	3.9	3.49	2.6	4.62
Leasehold Improvements	-	-	5.51	5.51	5.39	9.22

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q